David Chiswell, Ph.D.
Chairman of the Board, Albireo
After a career as a research scientist in both the United Kingdom and the United States and nine years working in scientific management at Amersham International, David Chiswell co-founded Cambridge Antibody Technology (CAT) and served as its CEO for several years. In addition to Albireo, Dr. Chiswell is currently CEO of Kymab Ltd and is a Director of Nabriva Therapeutics.
He was previously chairman of the UK’s BioIndustry Association (BIA) and remains on its board. In 2006 Dr. Chiswell was awarded the OBE by HM Queen for services to the biotechnology industry.